Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: Tricuspid valve endocarditis is more prevalent in the population of patients who inject intravenous drugs. The comorbidity of active addiction significantly complicates treatment in this population and multidisciplinary management is required.
Case Summary: A young man with a history of active injection drug use presented with isolated tricuspid valve endocarditis. The patient was deemed a poor surgical candidate because of active addiction. The patient underwent percutaneous vegectomy with successful aspiration of vegetation.
Discussion: Multidisciplinary management played a critical role in the patient's recovery and eventual surgical intervention. Although tricuspid valve endocarditis is common, management of active addiction complicates management. Currently no guidelines exist for management of infective endocarditis in intravenous drug use.
Take-home Messages: Percutaneous vegectomy can be a useful tool to reduce morbidity and mortality in patients with drug use-related infective endocarditis. Multidisciplinary management is critical for success in these high-risk patients.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jaccas.2025.104347 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Surgically Treated Giant Right Atrium in Isolated Severe Tricuspid Regurgitation.
World J Pediatr Congenit Heart Surg
September 2025
Department of Pediatric Cardiac Surgery, National Institute of Cardiovascular Diseases, Karachi, Pakistan.
Severe tricuspid regurgitation (TR) can lead to significant enlargement of the right atrium (RA) and poses unique clinical challenges. We report this case of a 17-year-old boy previously misdiagnosed with Ebstein anomaly who presented with dyspnea and palpitations. Initial examination revealed irregular heart rhythm, distended neck veins, and a significant murmur.
View Article and Find Full Text PDFOutcomes of the Fontan operation in patients with Ebstein anomaly: An Australia and New Zealand Fontan registry study.
JTCVS Open
August 2025
Division of Cardiovascular Surgery, Children's National Heart Institute, Children's National Hospital, Washington, DC.
Objectives: We sought to review the outcomes of patients with Ebstein anomaly (EA) after the Fontan operation.
Methods: Patients with EA were identified from a large binational registry about the Fontan operation. Data were collected from hospital records, registry data, and clinical correspondence.
Outcomes of surgical management of carcinoid heart disease in patients with primary gonadal neuroendocrine tumors.
JTCVS Open
August 2025
Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minn.
Objectives: To describe the clinical presentation of patients with gonadal neuroendocrine tumors and carcinoid heart disease (CaHD) and to evaluate long-term outcomes following valvular surgery.
Methods: Retrospective review of patients with primary gonadal neuroendocrine tumor who were surgically treated for CaHD at our institution between 1990 and 2021.
Results: Eight patients (median age, 70 years) were included in the study, 7 with ovarian tumors and 1 with testicular tumor.
The complex and hazardous course for heterotaxy-associated congenital heart disease.
JTCVS Open
August 2025
Division of Cardiothoracic Surgery, Department of Surgery, University of Southern California, Los Angeles, Calif.
Objective: Patients with heterotaxy-associated congenital heart disease often require multiple operations, which may have a cumulative effect on their outcomes. This study aimed to define the cardiac surgical course in a large cohort and identify longitudinal risk factors for death/transplant.
Methods: All patients with heterotaxy-associated congenital heart disease who underwent cardiac surgery at one institution from 2005 to 2022 were retrospectively reviewed.
Objective: Minimally invasive aortic valve replacement (MIAVR) and transcatheter aortic valve replacement (TAVR) represent less-invasive alternatives to conventional surgical aortic valve replacement. In contrast to Society of Thoracic Surgeons (STS) Database data revealing <10% of all surgical aortic valve replacement procedures are performed via a minimally invasive approach, our center performs a high volume of MIAVR procedures. This propensity-score matched study aims to compare the outcomes of MIAVR versus TAVR in low-risk patients (STS Predicted Risk of Mortality <4%).
View Article and Find Full Text PDF